Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Lymphoma, B-Cell × Radiotherapy × Clear all

Phase

Phase 2 3 Phase 1 2 Phase NA 1 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 53 Prostatic Neoplasms 45 Carcinoma, Non-Small-Cell Lung 35 Squamous Cell Carcinoma of Head and Neck 33 Lung Neoplasms 33 Lymphoma 32 Head and Neck Neoplasms 29 Leukemia 20 Brain Neoplasms 20 Central Nervous System Neoplasms 19 Precursor Cell Lymphoblastic Leukemia-Lymphoma 17 Glioblastoma 17 Uterine Cervical Neoplasms 16 Esophageal Squamous Cell Carcinoma 16 Esophageal Neoplasms 16 Sarcoma 15 Rectal Neoplasms 15 Lymphoma, Follicular 15 Lymphoma, Large B-Cell, Diffuse 13 Hodgkin Disease 13 Burkitt Lymphoma 13 Oligodendroglioma 12 Lymphoma, Non-Hodgkin 11 Astrocytoma 11 Adenocarcinoma of Lung 11 Neoplasm Metastasis 10 Rhabdomyosarcoma 9 Nasopharyngeal Carcinoma 9 Lymphoma, Large-Cell, Immunoblastic 9 Neuroblastoma 8

Interventions

Rituximab 12 pirtobrutinib 5 ibrutinib 4 Vincristine 3 Doxorubicin 3 Cytarabine 3 zanubrutinib 2 Prednisone 2 Etoposide 2 Cyclophosphamide 2 Bendamustine Hydrochloride 2 venetoclax 1 tositumomab I-131 1 idelalisib 1 ibritumomab tiuxetan 1 etoposide phosphate 1 entecavir 1 cirmtuzumab 1 axicabtagene ciloleucel 1 acalabrutinib 1 VAP-cyclo protocol 1 Tenofovir 1 Radiotherapy 1 Methotrexate 1 Melphalan 1 Ifosfamide 1 Gemcitabine 1 Drug Therapy 1 Dexamethasone 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00841945 2017-02-23

Treatment of Aggressive Localized Lymphoma

French Innovative Leukemia Organisation

Phase 3 Terminated

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡